Status:
UNKNOWN
Effects of Ambulation Training Utilizing an Exoskeleton Robot on Subjects With Spinal Cord Injury
Lead Sponsor:
China Medical University Hospital
Conditions:
Spinal Cord Injuries
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
The present study aims to investigate the effects of ReWalk exoskeleton robot training on various physiological and psychological parameters among subjects with spinal cord injury, including body comp...
Detailed Description
The loss of upright mobility has a profound effect on the health and quality of life for individuals with a spinal cord injury (SCI). The ReWalk exoskeleton is an FDA-cleared, wearable, computer-contr...
Eligibility Criteria
Inclusion
- Between the age of 20-65 years old;
- Have paraplegia resulting from thoracic or lumbar spinal cord injury.
- At least 6 months after onset of the spinal cord injury
- Well motivated and willing to participate 40 hours of ReWalk ambulation training sessions.
Exclusion
- Have spinal cord injury neurologic level above T4
- Height greater than 190 cm or lower than160 cm
- Weight greater than 100 kg
- Have osteoporosis (T-score \< -2.5)
- Deep vein thrombosis
- Severe orthostatic hypotension precluding standing and walking training
- Pregnancy
- Cognitive impairments that would impact on the safe participation in the study
- Severe spasticity of lower limbs (Modified Ashworth Scale \>3)
- Contracture of the ankle, or a knee flexion contracture greater than 10 degrees
- Musculoskeletal conditions that affected gait capacity
- Co-existence of other neurological diseases
Key Trial Info
Start Date :
November 23 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03340792
Start Date
November 23 2017
End Date
December 31 2019
Last Update
January 8 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospial
Taichung, Taiwan, 404